Carolina's Medical Center, Charlotte, NC.
Assistant Vice President Patient Care Services, Carolina's Medical Center, Rock Hill, SC.
Semin Oncol Nurs. 2019 Apr;35(2):151-156. doi: 10.1016/j.soncn.2019.02.001. Epub 2019 Mar 11.
To provide an overview of the risk factors, modifiable and non-modifiable, for ovarian cancer as well as prevention, diagnostic, treatment, and long-term survivorship concerns. This article will also examine current and future clinical trials surrounding ovarian cancer.
A review of articles dated 2006-2018 from CINAHL, UpToDate, and National Comprehensive Cancer Network guidelines.
There is no screening test for ovarian cancer and with diagnosis often in the late stages, recurrence is high in this population. Early identification can range from knowing the vague symptoms associated with the cancer to prophylactic surgical removal of at-risk tissue. Standard treatment for ovarian cancer is surgery followed by combination chemotherapy. Although advances are being made, ovarian cancer remains the most fatal female gynecologic cancer.
Becoming familiar with and educating women about risk factors and the elusive symptoms of ovarian cancer can increase patient autonomy and advocacy, as well as potentially improve patient outcomes for those affected by ovarian cancer.
概述卵巢癌的风险因素,包括可改变和不可改变的因素,以及预防、诊断、治疗和长期生存问题。本文还将探讨当前和未来围绕卵巢癌的临床试验。
对 CINAHL、UpToDate 和国家综合癌症网络指南中 2006-2018 年的文章进行了回顾。
目前尚无卵巢癌筛查试验,且由于该疾病通常在晚期才被诊断,因此该人群的复发率较高。早期识别可以从了解与癌症相关的模糊症状到预防性切除高危组织。卵巢癌的标准治疗是手术加联合化疗。尽管取得了一些进展,但卵巢癌仍然是女性妇科癌症中最致命的癌症。
熟悉并向女性宣传卵巢癌的风险因素和隐匿症状,可以提高患者的自主权和倡导能力,并有可能改善受卵巢癌影响的患者的结局。